News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,598 Results
Type
Article (41285)
Company Profile (265)
Press Release (687032)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (204814)
Career Advice (2029)
Deals (35570)
Drug Delivery (128)
Drug Development (81489)
Employer Resources (173)
FDA (16485)
Job Trends (14974)
News (346742)
Policy (32753)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2594)
Accelerated approval (45)
Adcomms (25)
Allergies (167)
Alliances (49590)
ALS (200)
Alzheimer's disease (1764)
Antibody-drug conjugate (ADC) (425)
Approvals (16846)
Artificial intelligence (632)
Autoimmune disease (253)
Automation (52)
Bankruptcy (362)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (217)
Biotechnology (175)
Bladder cancer (184)
Brain cancer (68)
Breast cancer (717)
Cancer (5629)
Cardiovascular disease (455)
Career advice (1720)
Career pathing (41)
CAR-T (316)
CDC (54)
Celiac Disease (2)
Cell therapy (843)
Cervical cancer (45)
Clinical research (70544)
Collaboration (2000)
Company closure (4)
Compensation (1329)
Complete response letters (77)
COVID-19 (2734)
CRISPR (103)
C-suite (1060)
Cystic fibrosis (150)
Data (7500)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (73)
Diabetes (569)
Diagnostics (6887)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (306)
Drug pricing (198)
Drug shortages (31)
Duchenne muscular dystrophy (273)
Earnings (91341)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (118979)
Executive appointments (1057)
FDA (20087)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1672)
Gene editing (224)
Generative AI (54)
Gene therapy (681)
GLP-1 (1035)
Government (4716)
Grass and pollen (6)
Guidances (404)
Healthcare (18967)
HIV (77)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (278)
Immuno-oncology (86)
Indications (173)
Infectious disease (3066)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (282)
Interviews (317)
IPO (16656)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (557)
Leadership (37)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (752)
Lymphoma (421)
Machine learning (58)
Management (59)
Manufacturing (986)
MASH (179)
Medical device (13899)
Medtech (13992)
Mergers & acquisitions (20126)
Metabolic disorders (1451)
mRNA (193)
Multiple sclerosis (181)
NASH (17)
Neurodegenerative disease (395)
Neuropsychiatric disorders (101)
Neuroscience (3220)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4526)
Now hiring (75)
Obesity (679)
Opinion (283)
Ovarian cancer (206)
Pain (244)
Pancreatic cancer (286)
Parkinson's disease (351)
Partnered (33)
Patents (576)
Patient recruitment (635)
Peanut (61)
People (59432)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21989)
Phase 2 (31071)
Phase 3 (23127)
Pipeline (7831)
Policy (308)
Postmarket research (2567)
Preclinical (9362)
Press Release (64)
Prostate cancer (286)
Psychedelics (52)
Radiopharmaceuticals (317)
Rare diseases (1027)
Real estate (5965)
Recruiting (70)
Regulatory (25233)
Reports (55)
Research institute (2410)
Resumes & cover letters (353)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (172)
Series A (278)
Series B (207)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3632)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1076)
Venture capital (102)
Weight loss (437)
Women's health (120)
Worklife (20)
Date
Today (161)
Last 7 days (711)
Last 30 days (2805)
Last 365 days (30285)
2026 (10292)
2025 (30170)
2024 (35211)
2023 (40072)
2022 (51173)
2021 (55708)
2020 (54082)
2019 (46542)
2018 (35018)
2017 (32109)
2016 (31481)
2015 (37553)
2014 (31321)
2013 (26350)
2012 (28573)
2011 (29265)
2010 (27335)
Location
Africa (740)
Alabama (91)
Alaska (7)
Arizona (341)
Arkansas (14)
Asia (39587)
Australia (6484)
California (12747)
Canada (3647)
China (1291)
Colorado (546)
Connecticut (550)
Delaware (389)
Europe (85565)
Florida (1911)
Georgia (409)
Hawaii (3)
Idaho (62)
Illinois (1019)
India (88)
Indiana (581)
Iowa (23)
Japan (513)
Kansas (129)
Kentucky (49)
Louisiana (39)
Maine (75)
Maryland (1529)
Massachusetts (9076)
Michigan (353)
Minnesota (693)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3376)
New Mexico (28)
New York (3350)
North Carolina (1613)
North Dakota (8)
Northern California (6355)
Ohio (378)
Oklahoma (23)
Oregon (41)
Pennsylvania (2571)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5016)
Tennessee (206)
Texas (2015)
United States (45049)
Utah (379)
Vermont (1)
Virginia (304)
Washington D.C. (80)
Washington State (1024)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
728,598 Results for "medeon biodesign inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scala Biodesign Raises $16M Series A Financing to Accelerate Development of Protein-Based Products with ScalaOS
March 31, 2026
·
4 min read
Bio NC
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
Milestone® Pharmaceuticals Inc. announced upcoming data presentations on etripamil at ISPOR 2024 being held in Atlanta, GA on May 5-8, 2024, the 2024 Stanford BioDesign Arrhythmia Technologies Retreat in Boston, MA, on May 15, 2024, and the Annual meeting of the Heart Rhythm Society, Heart Rhythm 2024, in Boston, MA on May 16-19, 2024.
May 2, 2024
·
1 min read
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
Sofinnova Partners announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.
January 4, 2024
·
3 min read
Press Releases
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
December 9, 2024
·
2 min read
Deals
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers
Vector Laboratories today announced the acquisition of Quanta BioDesign.
July 17, 2023
·
3 min read
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc., a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign Prostatic Hyperplasia treatment solution.
January 27, 2021
·
4 min read
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
Press Releases
Axogen, Inc. Reports First Quarter 2026 Financial Results
April 28, 2026
·
18 min read
Press Releases
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - April 28, 2026
April 29, 2026
·
1 min read
Press Releases
Climb Bio, Inc. Announces $110.0 Million Private Placement
April 28, 2026
·
6 min read
1 of 72,860
Next
